Minimus Spine manufactures the Triojection system for herniated spinal discs. The company is dedicated to non-surgical treatment of herniated discs.
Mr. Binder was Biomet’s CEO from 2007 to 2015, when Zimmer acquired the company for $14 billion. He also has experience as president of Abbot Diagnostics and CEO of Spinal Concepts. He is currently the president and CEO of Immucor.
“Jeff brings a wealth of intellect and experience to Minimus,” said David Hooper, PhD, President and CEO of Minimus Spine. “He has successfully orchestrated several significant transactions in spine and orthopedics and is unquestionably a blue-chip addition as we strengthen the team around Triojection.”
More articles on spine devices:
Mazor Robotics brings in record year with $36.4M in 2016 revenue—16 highlights
Alphatec Spine adds David Mowry to board of directors
NuVasive surpasses full-year 2016 expectations; reports $962.1M in revenue
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
